Aerie Pharmaceuticals Skyrockets On Eye Drug News

September 14, 2016 8:10 PM

14 0

Aerie Pharmaceuticals (AERI) spiked before the open on the stock market today after reporting positive trial data for an eye pressure drug late Wednesday.

In a late-stage trial, Aerie Pharma's Roclatan lowered fluid pressure within the eye, outperforming latanoprost or Rhopressa, another Aerie treatment.

Also read: Trial date set for alleged driver in crash that killed 4

Read more

To category page